Procurement Summary
Country : Brazil
Summary : Price Registration for Future Acquisition of Medicines.
Deadline : 16 Jul 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 122073539
Document Ref. No. : 90079/2025
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Subject: Electronic Auction - Price Registration for Future Medicines Acquisition.
UASG Code: 928285
Notice from: 03/07/2025 from 08:00 to 12:00 and from 13:00 to 17:00
Proposal Delivery: From 07/03/2025 to 08:00
Anidilafunigina, 100 mg concentration, pharmaceutical form Injectable Liophile Powder
Quantity: 300
Captopril, concentration 25 mg
Quantity: 40000
Carvedilol, dosage 6.25 mg
Quantity: 30000
Cephalexin, dosage 500 mg
Quantity: 1500
CEFAZOLINE Sodium, concentration 1 g, pharmaceutical form powder for injectable solution
Quantity: 6000
Cefepima Hydrochloride, Concentration 2 g, pharmaceutical form lipyl powder for injectable
Quantity: 2000
Ciprofloxacin hydrochloride, dosage 500 mg
Quantity: 6000
Chlorpromazine, dosage 5 mg/ml, presentation injectable solution
Quantity: 3000
Sodium dantrolene, 20 mg concentration, injectable presentation, characteristic Additional kit w/ 12frs lyophilized powder + 12frs w/ diluent
Quantity: 60
Daptomycin, 500 mg concentration, pharmaceutical form lipyl powder for injectable
Quantity: 100
Escetamine, concentration 50 mg/ml, pharmaceutical form injectable solution
Quantity: 10000
Diazepam, dosage 5 mg/ml, presentation Injectable solution
Quantity: 6000
Dobutamine hydrochloride, dosage 12.5 mg/ml, injectable indication
Quantity: 3000
DOMPERIDONA, dosage 10 mg
Quantity: 15000
Enoxaparin, concentration 100 mg/ml, pharmaceutical form injectable solution, additional characteristics 1 filled syringe
Amount : 4000
Fentanilla, presentation Citrate salt, dosage 0.05 mg/ml, indication injectable solution
Quantity: 40000
Formoterol Fumarato, composition associated with Budesonide, concentration 6 mcg +200 mcg/ dose, pharmaceutical form aerosol suspension for inhalation, additional characteristics with inhaler vial
Amount : 1000
Potassium phosphate, mono composition ...
Documents
Tender Notice